Analysis of ASMs and male infertility using the FDA adverse event reporting system (FAERS)
Kunyang An, Jingyu Xu, Yujia Xi, Xinfang Cao, Jingqi Wang, Xiaoqin Hu, Xuezhi Liang · 2026
Read Analysis of ASMs and male infertility using the FDA adverse event reporting system (FAERS) by Kunyang An, Jingyu Xu, Yujia Xi, Xinfang Cao, Jingqi Wang, Xiaoqin Hu, Xuezhi Liang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12884394.txt.
Description
Kunyang An and co-authors mine the FDA's adverse-event database for links between seizure medicines and male infertility in a study whose head dates it to 2025. Epilepsy drugs anchor treatment, yet their reproductive effects are under-watched even though male factors drive half of infertility. Reports from 2004 to 2024 were deduplicated and screened with two signal-detection methods.
Among over eighty-one thousand reports on the specified drugs, sixty concerned male infertility. Carbamazepine and valproic acid showed the strongest signals, with reporting odds roughly nine and seven times expectation. Three more drugs signaled positively, while three others showed none. Most reports came from the United States and working-age men. The authors urge fertility monitoring for men on these medicines and further study, while noting the database's limits.
Catalog record
| CREATOR | Kunyang An, Jingyu Xu, Yujia Xi, Xinfang Cao, Jingqi Wang, Xiaoqin Hu, Xuezhi Liang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |